Related by context. All words. (Click for frequent words.) 78 Aflibercept 75 Epratuzumab 75 targeted radiotherapeutic 74 Nexavar ® 74 Alemtuzumab 74 Archexin 74 proteasome inhibitor 74 Pertuzumab 74 Phase #b/#a clinical 74 FOLOTYN ® 73 CYT# potent vascular disrupting 73 Ocrelizumab 73 RhuDex ® 73 multi kinase inhibitor 73 Apixaban 73 LymphoStat B belimumab 73 MAGE A3 ASCI 73 MKC# MT 73 sorafenib tablets 73 Vicriviroc 73 Romidepsin 73 IMA# 73 Golimumab 73 Phase Ib IIa 72 oral proteasome inhibitor 72 volociximab 72 Personalized Immunotherapy 72 Eculizumab 72 Pirfenidone 72 acyclovir Lauriad R 72 Meets Primary Endpoint 72 Temsirolimus 72 INSPIRE Trial Phase III 72 beta 1a 72 Mipomersen 72 non nucleoside inhibitor 72 Phase 2b Clinical Trial 72 XL# XL# 72 orally administered inhibitor 72 YONDELIS 72 R sorafenib tablets 72 Teriflunomide 72 relapsed leukemia 72 GW# [003] 72 PrevOnco 72 docetaxel Taxotere R 72 mertansine 71 Ridaforolimus 71 XL# anticancer compounds 71 Investigational Treatment 71 Silodosin 71 thetreatment 71 Annamycin 71 metastatic colorectal 71 Panzem R NCD 71 elotuzumab 71 Amrubicin 71 ospemifene 71 Vandetanib 71 Pazopanib 71 radiation sensitizer 71 LymphoStat B TM 71 IgG1 monoclonal antibody 71 Allovectin 7 71 evaluating tivozanib 71 dasatinib Sprycel ® 71 Tezampanel 71 Factor VIIa 71 DEB# 71 relapsing multiple sclerosis 71 GVAX ® 71 MKC# MKC# PP 71 receptor tyrosine kinase inhibitor 71 KRN# 71 sorafenib Nexavar 71 Achieves Primary Endpoint 71 hypoxia activated prodrug 71 Dalbavancin 71 Anidulafungin 71 EOquin TM phase 71 Pimavanserin 71 Sapacitabine 71 Xanafide 71 Ixempra 71 Omacetaxine 71 huC# DM4 71 Elagolix 71 AKT inhibitor 71 XL# XL# XL# 71 Tanespimycin 71 regorafenib 71 CD# monoclonal antibody 70 Campath ® 70 PDE4 inhibitor 70 oncolytic virus therapies 70 generation purine nucleoside 70 IL# PE#QQR 70 Dapagliflozin 70 Deforolimus 70 Maribavir 70 Liprotamase 70 Denufosol 70 pan HDAC inhibitor 70 Patients Treated With 70 Phase 1b clinical trials 70 Muraglitazar 70 Pemetrexed 70 reslizumab 70 Elotuzumab 70 HQK 70 Initiates Clinical Trial 70 Teplizumab 70 Trastuzumab DM1 70 pralatrexate injection folate analogue 70 Onalta TM 70 TBC# 70 Hsp# Inhibitor 70 Glufosfamide 70 investigational monoclonal antibody 70 novel VDA molecule 70 IAP inhibitors 70 Elvitegravir 70 erlotinib Tarceva ® 70 Bezielle 70 Completes Patient Enrollment 70 JAK inhibitor 70 IMC #B 70 Boceprevir 70 phase III isavuconazole 70 targeting CD# 70 essential thrombocythemia ET 70 Phase 2a Clinical Trial 70 ZACTIMA 70 RhuDex R 70 Immunotherapeutic 70 Phase IIb Trial 70 IMiDs ® 70 Panzem R 70 Bavituximab 70 Bortezomib 70 Tofacitinib 70 Initiate Clinical Trial 70 phase IIb clinical 70 Aliskiren 70 Cethromycin 70 IMPDH inhibitor 70 Hedgehog Pathway Inhibitor 70 class mGluR5 inhibitor 70 PF # [002] 70 OncoVex 70 PEGylated Fab fragment 70 rasagiline tablets 70 refractory chronic lymphocytic 70 Onalta 70 PD LID 70 Safinamide 70 Nitazoxanide 70 RhuDex TM 70 Initiate Phase 70 MKC# 69 Bayer HealthCare Onyx Pharmaceuticals 69 daclizumab 69 Tesetaxel 69 oral prodrug 69 Glatiramer Acetate 69 psoriasis rheumatoid arthritis 69 investigational humanized monoclonal antibody 69 SinuNase TM 69 docetaxel Taxotere ® 69 histone deacetylase HDAC inhibitor 69 metastatic hormone refractory 69 antibody MAb 69 OvaRex R 69 Crizotinib 69 Initiates Phase II 69 Genentech Rituxan 69 MyVax R 69 Vicinium TM 69 Xeloda ® 69 humanized monoclonal antibody 69 Degarelix 69 relapsed MM 69 JAK2 Inhibitor 69 Enzastaurin 69 PDX pralatrexate 69 Ustekinumab 69 Ofatumumab 69 peripherally acting 69 Initiates Enrollment 69 Temodar ® 69 liposomal formulation 69 nucleoside analog 69 NS5b 69 Cloretazine ® 69 MEK Inhibitor 69 PSMA ADC 69 Bucindolol 69 EOquin TM 69 Voreloxin 69 candidates Azedra TM 69 Receives Orphan Drug Designation 69 HDAC Inhibitor 69 hepatitis C HCV 69 AVONEX ® 69 oral dual endothelin 69 CCR5 receptor antagonist 69 oral dihydropyrimidine dehydrogenase DPD 69 Afatinib 69 GRN# 69 IV Busulfex 69 Epidermal Growth Factor Receptor 69 Lupus Nephritis 69 Naive Patients 69 AAG geldanamycin analog 69 Pradefovir 69 Phase 2b Trial 69 Tipranavir 69 cilengitide 69 oral Janus kinase 69 Monoclonal antibody 69 BCR ABL inhibitors 69 Combination REOLYSIN R 69 Ozarelix 69 dasatinib Sprycel 69 RhuDex 69 Pralatrexate 69 Valopicitabine 69 IMiDs R 69 oral ridaforolimus 69 Bosutinib 69 HuMax CD4 69 PNP inhibitor 69 Olaparib 69 IAP inhibitor 69 DU #b 69 lumiliximab 69 Vitrasert R 69 personalized cellular immunotherapy 69 alvespimycin 69 Virulizin ® 69 Initiates Clinical 69 Saxagliptin 69 vidofludimus 69 Kinase Inhibitor 69 novel immunotherapies 69 Gleevec resistant 69 Onco TCS 69 mTOR inhibitor 69 acetonide FA 69 Clofarabine 69 Civacir 69 Anti VEGF 69 RELOVAIR ™ 69 vinorelbine tartrate 69 Traficet EN 68 Pivotal Phase III 68 Tarceva TM 68 Talabostat 68 Methylnaltrexone 68 Fingolimod 68 Hormone Refractory Prostate Cancer 68 CTAP# Capsules 68 Iloperidone 68 Tesmilifene 68 KNS # 68 PEG SN# 68 OMP #R# 68 sunitinib Sutent 68 fostamatinib 68 Unit Dose Budesonide 68 BRAF inhibitor 68 ALN HPN 68 phase IIa clinical 68 Phase Ib clinical 68 investigational oral inhibitor 68 Laquinimod 68 Nexavar sorafenib 68 Everolimus 68 either acutely decompensated 68 Dacogen decitabine 68 Ixabepilone 68 immunotherapeutic agent 68 Irinotecan 68 chimeric monoclonal antibody 68 Arimoclomol 68 multicenter Phase III 68 SinuNase ™ 68 induced macular edema 68 compound INCB# 68 Perifosine 68 Prolongs Survival 68 Pafuramidine 68 Simulect 68 Curaxin 68 EndoTAG TM -1 68 Azacitidine 68 pertuzumab 68 Carfilzomib 68 Myocet 68 novel oral anticoagulant 68 Proxinium TM 68 vemurafenib 68 HyperAcute 68 Initiates Phase III 68 drug conjugate 68 recurrent NSCLC 68 recurrent metastatic ovarian cancer 68 inhaled formulation 68 LHRH receptor positive 68 potent topoisomerase II 68 IMiDs ® compound 68 Ceflatonin R 68 ALN PCS 68 Interferon beta 68 hormone LHRH antagonist 68 Telik logo TELINTRA 68 CDP# 68 VEGFR2 inhibitor 68 OncoVEX GM CSF 68 interferon gamma 1b 68 Apaziquone 68 Ecallantide 68 Campath alemtuzumab 68 Allovectin 7 ® 68 oral ghrelin agonist 68 cetuximab Erbitux R 68 midstage clinical 68 Pivotal Phase 68 somatostatin analogue 68 orally bioavailable 68 treat benign prostatic 68 XYOTAX TM 68 metaglidasen 68 Sebivo 68 Solazed TM 68 tiapamil 68 Solazed 68 Pivotal Study 68 Deferiprone 68 bevacizumab Avastin ® 68 BioNumerik 68 Clevudine 68 gefitinib Iressa 68 Clolar ® 68 relapsing remitting MS RRMS 68 oral antiviral 68 Navelbine ® 68 Phase IIb clinical trials 68 molecular imaging radiopharmaceutical 68 selective immunoproteasome inhibitor 68 Ataluren 68 YONDELIS R 68 Files IND 68 Drug Candidate 68 BENLYSTA ® 68 MYDICAR ® 68 omacetaxine mepesuccinate 68 developing Bicifadine serotonin 68 polymerase inhibitor 68 etanercept Enbrel 68 pegylated interferons 68 candidate AQ4N 68 Iluvien ® 68 lintuzumab SGN 68 Phase IIIb clinical 68 Blinatumomab 68 INCB# [001] 68 kidney urologic 68 compound KOS 68 ADP receptor antagonist 68 humanized monoclonal 68 Aplidin 68 cardio renal 68 Nipent R 68 SAR# [004] 68 ixabepilone 68 Evoltra ® 68 PORxin TM 68 OHR/AVR# 68 Albuferon TM 68 Vitaxin 68 lexidronam injection 68 VELCADE melphalan 68 toenail onychomycosis 68 dimebon latrepirdine 68 CEQ# 68 Rilonacept 68 GRNVAC1 68 Velcade bortezomib 68 Alfimeprase 68 ularitide 68 baminercept 68 AEG# 68 Aurora Kinase 68 thalidomide Thalomid 68 oral picoplatin 68 Hepatocellular Carcinoma 68 LHRH antagonist 68 Allovectin 7 R 68 Onalta ™ 68 adalimumab Humira 68 Belimumab 68 PI3K/Akt pathway inhibitor 68 Zolinza 68 PARP inhibitor 68 virus HCV protease inhibitor 67 Aviptadil 67 factor Xa inhibitor 67 galiximab 67 Custirsen 67 HCV NS5B polymerase 67 VitiGam 67 Medidur ™ FA 67 Troxatyl 67 basiliximab 67 diarrhea predominant irritable 67 ILUVIEN ® 67 Randomized Phase 67 Ceflatonin 67 recurrent glioblastoma multiforme 67 SNT-MC#/idebenone 67 FDA APPROVES 67 Successfully Completes Phase 67 TYZEKA 67 Dasatinib 67 Novel Oral 67 peptidic compound 67 Zoraxel 67 Phase IIb Clinical Trial 67 relapsed multiple myeloma 67 Antiangiogenic 67 Plicera 67 methylnaltrexone bromide 67 Moxifloxacin 67 UPLYSO 67 sapacitabine CYC# 67 Tocilizumab 67 investigational immunotherapy 67 Tyrosine Kinase Inhibitor 67 canagliflozin 67 BAY #-# 67 IMiDs 67 Anavex #-# 67 Crofelemer budesonide foam 67 anti PlGF 67 Begins Dosing 67 CD# CEA 67 Gleevec imatinib mesylate 67 HuMax TAC 67 Mycophenolate Mofetil 67 Oral NKTR 67 Entecavir 67 humanised monoclonal antibody 67 metastatic malignant 67 Tykerb lapatinib 67 AFREZZA TM 67 Granted Orphan Drug 67 Elesclomol 67 OMAPRO ™ 67 miconazole Lauriad ® 67 Seliciclib 67 Dabigatran etexilate 67 First Patient Dosed 67 HCD# [002] 67 HCV polymerase 67 OMP #M# 67 ACTEMRA TM 67 Interferon beta 1a 67 hormone refractory metastatic prostate 67 esophageal candidiasis 67 Peginterferon alfa 2b 67 HuLuc# 67 PEG Interferon lambda 67 Hepatocellular Carcinoma HCC 67 multikinase inhibitor 67 Renal Cell Carcinoma 67 Investigational Compound 67 Genasense ® 67 Alvesco R 67 protein kinase inhibitor 67 visilizumab 67 ALN TTR 67 Telbivudine 67 intravesical infusion therapy 67 Zorbtive TM 67 Study Evaluating 67 Intravenous CP 67 LEUKINE 67 Pulmonary Arterial Hypertension 67 MOVIPREP R 67 Sudhir Agrawal D.Phil 67 Ophena TM 67 Mg Usa 67 Zalypsis 67 registrational trial 67 selective modulator 67 vapreotide acetate 67 PKC# 67 Panitumumab 67 Aclidinium 67 BCR ABL inhibitor 67 PORxin TM platforms 67 Ambrisentan 67 Advanced Renal Cell 67 Angiocept 67 vinca alkaloid 67 PNT# 67 SUTENT ® 67 Phase IIa trials 67 Azedra 67 LEVADEX TM 67 APEX PD 67 Eltrombopag 67 Advanced Melanoma 67 sodium glucose cotransporter 67 Aryplase 67 Antitumor Activity 67 R lenalidomide 67 Squalamine 67 including eniluracil ADH 67 Nanobody 67 trastuzumab Herceptin R 67 Pfizer Sutent 67 ® bortezomib 67 huN# DM1 67 Neulasta ® 67 PEGylated interferon 67 SNT MC# 67 Canvaxin 67 Phase 2b clinical trials 67 CIMZIA ™ 67 aerosolized AAT 67 Alocrest 67 Febuxostat 67 hypereosinophilic syndrome 67 Albugon 67 Cetrorelix 67 budesonide foam 67 Omnitarg 67 Diabetic Macular Edema DME 67 TACI Ig 67 Lung Cancer Drug 67 Tarvacin 67 humanized interleukin 6 67 mitogen activated ERK kinase 67 mild vasodilator 67 Liposomal 67 Alfacell proprietary ribonuclease 67 myelodysplastic myeloproliferative diseases 67 metastatic castration resistant 67 Fabry Disease 67 Therapeutic Vaccine 67 Litx 67 PROVENGE ® 67 Lixivaptan 67 humanized therapeutic 67 evaluating picoplatin 67 Phase Ib II 67 nonsmall cell lung cancer 67 Syncria 67 Darinaparsin 67 Phase III Clinical Trial 67 Trofex TM 67 aldehyde dehydrogenase ALDH2 deficiency 67 Bevacizumab 67 Pyridorin 67 BRIM2 67 immunotherapeutic vaccine 67 First Patient Enrolled 67 pediatric Crohn disease 67 Medidur TM FA 67 tolevamer 67 Telatinib 67 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 67 Erlotinib 67 Vidofludimus 67 delivers fluocinolone acetonide FA 67 EVIZON TM 67 Argatroban 67 TNF Tumor Necrosis Factor 67 Arcalyst 67 5 HT4 67 ocrelizumab 67 TELINTRA R 67 adult chronic ITP 67 Quinamed 67 Cancidas 67 telomerase therapeutic 67 M# rationally 67 FUSILEV ® 67 Fludara ® 67 vaginal candidiasis 67 Phase III Trial 67 5 HT2A inverse 67 Rituximab 67 Vidaza azacitidine 67 topically applied SEPA 67 marketed pegylated interferons 67 5 fluorouracil leucovorin 67 abacavir Ziagen 67 RANK Ligand inhibitor 66 Tigecycline 66 myelofibrosis polycythemia vera 66 biliary tract cancer 66 selective kinase inhibitor 66 Darusentan 66 Xcytrin R 66 Prospective Randomized 66 Phase 2a Trial 66 hyperplasia BPH 66 Lubiprostone 66 PANVAC VF 66 metastatic bladder 66 plus DOXIL 66 echinocandin 66 Phase Ib clinical trials 66 Fibrillex TM 66 nephropathic cystinosis 66 microtubule inhibitor 66 Entry Inhibitor 66 IMC #F# 66 Diabetic Neuropathy 66 signal transduction inhibitors 66 Anticancer Compound 66 pediatric acute lymphoblastic 66 hematological malignancy 66 Onconase 66 Phase III Pivotal 66 OvaRex ® MAb 66 orally dosed 66 Relapsed Refractory 66 sunitinib malate 66 Mitoxantrone 66 Canvaxin TM 66 JAK3 inhibitor 66 adecatumumab MT# 66 MT#/MEDI-# 66 intravesical instillation 66 Thiarabine 66 humanized antibody 66 PRT# 66 Clinical Trial Results 66 RNAi Therapeutic 66 lucinactant 66 Interferon Beta 66 Talactoferrin 66 Tramiprosate ALZHEMED TM 66 candidates Azedra 66 Aptivus ® 66 Panzem NCD 66 humanized anti 66 advanced metastatic renal 66 atacicept 66 nucleotide analogue 66 oral JAK#/JAK# inhibitor 66 Vertex hepatitis C 66 EDEMA3 66 Cimzia TM 66 RECOTHROM R 66 antisense drug 66 rituximab Rituxan 66 Gemzar ® 66 novel emulsion formulation 66 lipoglycopeptide 66 TASKi3 66 CA9 SCAN 66 pan histone deacetylase 66 successfully commercialize Iluvien 66 ANYARA 66 multiple myeloma MM 66 Antibody Drug Conjugate 66 bortezomib Velcade 66 mGluR2 positive 66 GTC recombinant human 66 MT# MEDI 66 substantially excreted 66 tenofovir disoproxil fumarate Viread 66 Ganciclovir 66 ZEVALIN ® 66 Cariprazine 66 Oral Fingolimod 66 metastatic gastric 66 Pegloticase 66 brivanib 66 Trial Evaluating 66 Romiplostim 66 Vivecon 66 Nuvion 66 rheumatoid arthritis psoriatic arthritis 66 rxRNA 66 rilonacept 66 GA GCB 66 ganetespib 66 Aurora kinase inhibitor 66 platelet inhibitor 66 Cloretazine 66 Gamunex C 66 Multiple Ascending Dose 66 Granulocyte Colony Stimulating Factor 66 TG# [003] 66 small molecule chemotherapeutic 66 Lenalidomide 66 Abbokinase 66 Bicifadine 66 Adjuvant Treatment 66 agonistic human 66 candidate REP# 66 tafamidis 66 Herceptin trastuzumab 66 Eraxis 66 R Saizen R 66 Racivir 66 Rebif ® 66 Toremifene 66 hyaluronidase enzyme 66 BrachySil 66 mGluR5 NAM 66 phase Ib clinical 66 anti CD3 monoclonal 66 Melphalan 66 Phase III Trials 66 Tasimelteon 66 Alinia 66 imatinib Gleevec ® 66 Adenosine Therapeutics 66 HCV RNA polymerase 66 MCSP respectively 66 Presents Preclinical Data 66 ALK inhibitors 66 tumor vascular disrupting 66 ketolide antibiotic 66 Cabazitaxel 66 DDP# 66 forodesine 66 monoclonal antibody MAb 66 TMC# [002] 66 severe hypercholesterolemia 66 Trabectedin 66 omega interferon 66 Otelixizumab 66 calcineurin inhibitor 66 Newly Diagnosed Multiple Myeloma 66 investigational pharmacologically unique 66 subcutaneous formulation 66 Fast Track Status 66 Mg Uk 66 octreotide acetate 66 catheter occlusion 66 metastatic neuroendocrine tumors 66 GSK '# 66 bendamustine 66 Pivotal Trial 66 RH1 66 CCR5 antagonist 66 phase IIa 66 highly selective endothelin 66 Intravitreal 66 P#X# antagonist 66 Novantrone 66 initiated Phase Ib 66 Noxafil 66 Sym# 66 treat chronic sinusitis 66 cannabinor 66 Neuvenge 66 INTEGRILIN ® 66 ALVESCO R 66 HepeX B TM 66 Iluvien TM 66 Gefitinib 66 markets HP Acthar 66 Diamyd R 66 TASKi2 66 Icatibant 66 Luteinizing Hormone Releasing Hormone 66 personalized immunotherapy 66 oral Hsp# inhibitor 66 mapatumumab 66 epothilones 66 pseudobulbar affect PBA 66 Hepatitis C HCV 66 noninfectious uveitis 66 SYN# 66 castrate resistant prostate cancer 66 metastatic castrate resistant 66 R#/MEM # 66 ATG Fresenius S 66 Frova ® 66 reduce serum phosphate 66 Patients Receiving 66 adenosine injection 66 TKB# 66 multitargeted 66 Transdermal Patch 66 DermaVir Patch 66 CYT# vascular disrupting 66 Taiho Pharmaceutical 66 Patient Enrollment 66 teriflunomide 66 Nilotinib 66 Initiates Phase 2b 66 CCR5 mAb 66 selective orally bioavailable 66 BrachySil TM 66 PHX# 66 TELINTRA 66 includes TOLAMBA TM 66 HuMax EGFr 66 Syncria R 66 CB2 selective receptor agonist 66 nilotinib Tasigna ® 66 small molecule tyrosine 66 antibody MT# 66 multicenter Phase II 66 R roscovitine 66 Cx# [002] 66 alefacept 66 BARACLUDE R 66 novel histone deacetylase 66 CCX# B 66 accumulate preferentially 66 TRX1 66 seliciclib CYC# 66 GRNOPC1 contains 66 Onyx Pharmaceuticals Announces 66 Zoraxel TM 66 Psoriasis Drug 66 LHRH antagonists 66 brand ciclesonide HFA 66 unresectable tumors 66 LEP ETU 66 mesylate 66 JAK2 inhibitor 66 Pivotal Clinical Trial 66 Renal Cell Carcinoma RCC 66 oral talactoferrin 66 unique alkylating agent 66 CIMZIA TM certolizumab pegol 66 Phase III Clinical Trials 66 targeted antifolate 66 ATL# [001] 66 oral salmon calcitonin 66 Fx #A 66 Anti Tumor 66 NP2 Enkephalin 66 lenalidomide Revlimid R 66 Refractory Angina 66 PLK1 SNALP 66 orBec 66 triggers apoptosis programmed 66 refractory metastatic 66 Zemplar Capsules 66 Kamada AAT 66 AA Amyloidosis 66 BUPHENYL R 66 protein tyrosine phosphatase 1B 66 GV# [001] 66 Oglemilast 66 orally inhaled migraine 66 EGS# 66 ORENCIA R 66 HCV protease inhibitor 66 subcutaneously administered 66 RAPTIVA 66 DP VPA 66 ToGA 66 Tyrima 66 acute peripheral arterial 66 HepDirect prodrug 66 alemtuzumab Campath 66 Investigational Oral 66 intranasal formulation 66 Panzem 66 Pooled Analysis 66 Humanized Anti 66 Sustiva efavirenz 66 Cannabinor 66 modified glutathione analog 66 STEDESA 66 AVASTIN 66 Orphan Status 66 Camptosar ® 66 Neulasta R 66 albiglutide 66 PrevOnco ™ 66 AMPK activators 66 Satraplatin 66 small molecule Hedgehog 66 Long Term Efficacy 66 Oral Calcitonin 66 apomorphine hydrochloride 66 pemphigus vulgaris 66 Copegus ® 66 HSP# inhibitor 66 Alzheimer disease cognitive impairment 66 CCX# 66 Previously Treated 65 Adentri 65 pegylated interferon alfa 2a 65 Acute Exacerbations 65 Naproxcinod 65 Peginterferon 65 Severe Sepsis 65 Lenocta 65 Atrasentan 65 Tolvaptan 65 Bafetinib 65 trastuzumab DM1 65 PEGylated interferon beta 1a 65 GATTEX TM 65 Smac mimetics 65 investigational integrase inhibitor 65 ceftazidime 65 Plecanatide 65 Natalizumab 65 NS5B polymerase 65 2 methoxyestradiol 65 Protease Inhibitors 65 vitreoretinal disorders 65 EP #R 65 Phase 1b Clinical Trial 65 lymphoid malignancies 65 Systemic Delivery 65 acadesine 65 midstage trials 65 tyrosine kinase inhibitor TKI 65 Pagoclone 65 occlusion PAO 65 Fulvestrant 65 ara C 65 Letairis ambrisentan 65 ELACYT 65 StromaCel Inc. 65 CYC# 65 opioid induced bowel dysfunction 65 Besivance 65 Torisel 65 elvucitabine 65 Alvine Pharmaceuticals 65 Cetuximab Erbitux 65 neuropathic pain spasticity 65 Randomized Phase II 65 therapeutic monoclonal antibody 65 neratinib 65 BMS # 65 ProMune 65 Exelixis XL# 65 Avanafil 65 eribulin mesylate 65 gamma secretase inhibitor 65 Unresectable 65 Adjunctive Therapy 65 cholesteryl ester transfer 65 phase IIb 65 Certolizumab pegol 65 Bayer Nexavar 65 Crofelemer 65 Saforis 65 Exelixis compounds 65 Pruvel TM 65 Presents Preclinical 65 relapsed refractory multiple myeloma 65 OvaRex 65 Vaccine Adjuvant 65 docetaxel Taxotere 65 adenosine A2A 65 generation proteasome inhibitor 65 MEK inhibitor 65 molecular chaperone regulator 65 trastuzumab DM1 T DM1 65 Inhaled nitric oxide 65 Fondaparinux 65 LymphoStat B 65 sunitinib Sutent ® 65 PEG interferon 65 ThermoDox R 65 ulcerative colitis Crohn disease 65 PLX MS 65 riociguat 65 paclitaxel Taxol ® 65 Novel Therapeutic 65 Diamyd ® 65 non peptidic protease 65 NV1FGF 65 Dementia Related Psychosis 65 Radezolid 65 cutaneous T 65 Benign Prostatic Hyperplasia 65 prokinetic agent 65 Retisert ® 65 hepatitis B HBV 65 ENMD # 65 MTP inhibitor 65 5 FU capecitabine 65 telaprevir VX 65 Kuvan sapropterin dihydrochloride 65 Cethrin R 65 aflibercept VEGF Trap 65 generation Hsp# inhibitor